| IBD n = 54,293 | Non-IBD n = 54,293 | Outcome risk | ||||
---|---|---|---|---|---|---|---|
Subgroup | Incident case | Incidence per 1000 person-years | Incident case | Incidence per 1000 person-years | IRR | aHR (95% CI) | p |
All patients | 3421 | 8.18 | 2295 | 5.42 | 1.51 | 1.43 (1.35 – 1.51) | < .0001 |
Age group, years | |||||||
 0–19 | 259 | 1.67 | 186 | 1.20 | 1.40 | 1.36 (1.12 – 1.64) | 0.0015 |
 20–39 | 813 | 6.97 | 524 | 4.44 | 1.57 | 1.49 (1.33 – 1.67) | < .0001 |
 40–59 | 1419 | 1.17 | 926 | 0.74 | 1.57 | 1.46 (1.34 – 1.58) | < .0001 |
 ≥ 60 | 930 | 1.72 | 659 | 1.19 | 1.45 | 1.32 (1.19 – 1.46) | < .0001 |
Sex | |||||||
 Male | 1034 | 5.02 | 679 | 3.27 | 1.54 | 1.43 (1.30 – 1.58) | < .0001 |
 Female | 2387 | 11.26 | 1616 | 7.48 | 1.51 | 1.43 (1.34 – 1.52) | < .0001 |
Charlson comorbidity index | |||||||
 0 | 2881 | 7.55 | 2001 | 5.10 | 1.48 | 1.42 (1.34 – 1.51) | < .0001 |
 1 | 431 | 15.40 | 215 | 9.17 | 1.68 | 1.51 (1.28 – 1.78) | < .0001 |
 2 | 90 | 13.25 | 70 | 11.01 | 1.20 | 1.09 (0.78 – 1.50) | 0.6223 |
 ≥ 3 | 19 | 13.13 | 9 | 5.16 | 2.54 | 2.35 (0.99 – 5.56) | 0.0519 |
Use of systemic corticosteroids | |||||||
 Yes | 756 | 10.21 | 388 | 7.02 | 1.45 | 1.31 (1.16 – 1.49) | < .0001 |
 No | 2665 | 7.75 | 1907 | 5.18 | 1.50 | 1.45 (1.37 – 1.54) | < .0001 |